The global animal imaging market is anticipated to grow with a CAGR of 6.78% over the forecast period, i.e., 2022-2031. Factors such has growing zoonotic disease followed by rapid urbanization & an increase in disposable incomes are projected to drive the growth of the market in the coming years. Additionally, growing number of pet owners, and also surge in demand for veterinary services is estimated to boost the market growth. The market is estimated to garner a revenue of near to USD 3,600 Million by the end of 2031, up from a revenue of about USD 1,900 Million in the year 2021.
The global animal imaging market is segmented into numerous segments, which include segmentation by type, and by animal type. By animal type, the market is segmented into small animal, and large animal. By the end of 2031, the small animal segment is anticipated to garner the largest revenue.
On the basis of region, the global animal imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America, amongst the market in all other regions, is anticipated to garner the largest revenue of more than USD 1,200 Million by the end of 2031. Moreover, in the year 2021, the market in this region generated a revenue of over 600 Million.
Some of the prominent industry leaders in the global animal imaging market that are included in our report are IDEXX Laboratories, Inc., Esaotae SPA, Carestream Health, Inc., GE Healthcare, Virbac Group, Elanco Animal Health, Merck Animal Health, Heska Corporation, MXR Imaging Inc., VCA Animal Hospitals, Kyoritsu Seiyaku Corporation, and SHIMA laboratories Co., Ltd. The market research report also covers an in-depth analysis of the reagent manufactures who are associated with animal imaging, the profiling of which includes organizations such as Promega Corporation, PerkinElmer Inc., Bayer AG, Merck & Co., Inc., and Thermo Fisher Scientific.
The global animal imaging market is segmented into numerous segments, which include segmentation by type, and by animal type. By animal type, the market is segmented into small animal, and large animal. By the end of 2031, the small animal segment is anticipated to garner the largest revenue.
On the basis of region, the global animal imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America, amongst the market in all other regions, is anticipated to garner the largest revenue of more than USD 1,200 Million by the end of 2031. Moreover, in the year 2021, the market in this region generated a revenue of over 600 Million.
Some of the prominent industry leaders in the global animal imaging market that are included in our report are IDEXX Laboratories, Inc., Esaotae SPA, Carestream Health, Inc., GE Healthcare, Virbac Group, Elanco Animal Health, Merck Animal Health, Heska Corporation, MXR Imaging Inc., VCA Animal Hospitals, Kyoritsu Seiyaku Corporation, and SHIMA laboratories Co., Ltd. The market research report also covers an in-depth analysis of the reagent manufactures who are associated with animal imaging, the profiling of which includes organizations such as Promega Corporation, PerkinElmer Inc., Bayer AG, Merck & Co., Inc., and Thermo Fisher Scientific.
Table of Contents
1. Market Definition
3. Research Methodology
5. Market Dynamics
13. Competitive Landscape
14. Global Animal Imaging Market
15. North America Animal Imaging Market
16. Latin America Animal Imaging Market
17. Europe Animal Imaging Market
18. Asia Pacific Animal Imaging Market
19. Middle East and Africa Animal Imaging Market
Companies Mentioned
- IDEXX Laboratories Inc.
- Esaotae SPA
- Carestream Health Inc.
- GE Healthcare
- Virbac Group
- Elanco Animal Health
- Merck Animal Health
- Heska Corporation
- MXR Imaging Inc.
- VCA Animal Hospitals
- Kyoritsu Seiyaku Corporation
- SHIMA laboratories Co. Ltd.
- Bayer AG
- Merck & Co. Inc.
- Thermo Fisher Scientific.
